SAN FRANCISCO – While more than 200 coronavirus treatments are being tested around the world, one UCSF doctor is running a trial to see if stem cells can help repair the lungs of those who have been severely impacted by COVID-19.
Doctor Michael Matthay, a professor of medicine at UCSF, has been working for days on end to lead a clinical trial that aims to help critically ill patients recover from COVID-19.
“We need additional treatment to further decrease the lung injury and increase the repair, and so this cell-based therapy has that potential,” Dr. Matthay said.
By using the stem cells derived from the bone marrows of healthy donors, Dr. Matthay explains how patients will be able to get off ventilators sooner and have a better chance of surviving.
“The problem that many patients encounter or face when they develop this COVID-19 virus is that the virus can go into the lungs and cause injury to the lungs – making it difficult for the patient to breathe normally,” Dr. Matthay said.
He says the coronavirus also causes inflammation and respiratory failure, but if the treatment is effective, the damage to the lungs will be reduced.
Dr. Matthay says the